News
Looking at licensing deals struck in the past 10 years, Jefferies found that many Big Pharmas do not ultimately follow ...
Merck (MRK) stock is in focus as its Enflonsia RSV shot is cleared for infants in the U.S. in a market led by Sanofi (SNY) ...
4h
VnExpress International on MSNTerumo Vietnam, Sanofi-Aventis Vietnam partner to enhance interventional cardiology expertiseTerumo Vietnam Medical Equipment (Terumo Vietnam) and Sanofi-Aventis Vietnam signed a two-year cooperation agreement to ...
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...
BioSpace did a deep dive into executive pay, examining the highest compensation packages, pay ratios and golden ...
S hares of global vaccine makers were muted on Tuesday as investors and analysts took a "wait and watch" approach after U.S.
Explore more
Major vaccine policy changes could be on the horizon as the HHS removes key advisors. Click for my thoughts on what this may ...
During a live event, Gary J. Schiller, MD, explored the outcomes of the phase 1/2 trial of tagraxofusp-erzs in patients with ...
Pharmalittle: We’re reading about a Merck shot for RSV, a lawsuit over an Arkansas PBM law, and more
Merck won FDA approval for a shot that protects against RSV, the most common cause of hospitalization among infants ...
1h
The Punch on MSNNigeria’s manufacturing: A call for revampONCE heralded as a cornerstone of Africa’s industrial future, Nigeria’s manufacturing sector is in deep distress, calling for ...
As Head of R&D and a member of the Executive Leadership Team, the Company's research, development and medical affairs ...
ABUJA, NIGERIA / ACCESS Newswire / June 10, 2025 / In an era where healthcare disparities continue to challenge communities worldwide, five visionary pharmacists are making remarkable strides in revol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results